ea0016p99 | Bone and calcium | ECE2008
Pura Mikulas
, Kottler Marie-Laure
, Vanuga Peter
, Carreau Serge
, Vitesnik Karel
, Mittre Herve
To date only seven cases of naturally occuring inactivating mutations of the aromatase gene in men have been documented. Osteoporosis is one of the typical signs of the aromatase deficiency in male patients. We report results of estrogen therapy in patient with formerly described frameshift mutation of the CYP19 gene, ins 1058 T. Bone mineral density (BMD) was assessed during three phases of estrogen therapy. Patient was substituted by calcium and vitamin D throughout t...